Wolverine Trading, LLC Applied Therapeutics Inc. Call Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$4.35 - $8.5 $13,484 - $26,350
3,100 Added 14.22%
24,900 $211,000
Q2 2024

Aug 14, 2024
BUY
$4.04 - $6.37 $88,072 - $138,866
21,800 New
21,800 $101,000
Q4 2023

Feb 14, 2024
BUY
$1.84 - $3.35 $42,320 - $77,050
23,000 New
23,000 $77,000
Q3 2022

Nov 14, 2022
BUY
$0.86 - $1.55 $10,750 - $19,375
12,500 New
12,500 $12,000

Others Institutions Holding APLT

# of Institutions
140
Shares Held
112M
Call Options Held
1.68M
Put Options Held
1.91M
View Full List

About Applied Therapeutics Inc.

APLT Quotes by TradingView
  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $462M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email